Drug data last refreshed 11h ago · AI intelligence enriched 1w ago
Selenomethionine Se-75 is a radioactive diagnostic agent administered by injection used for imaging and diagnostic purposes in nuclear medicine. As a radiopharmaceutical, it localizes in specific tissues to enable visualization and assessment of organ function or pathology. The mechanism involves incorporation of selenium-75 into organic compounds that target particular anatomical regions.
As a legacy radiopharmaceutical approaching loss of exclusivity, this product likely operates with a small, specialized team focused on maintenance rather than growth.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
With zero linked job openings, Selenomethionine Se-75 represents a niche legacy product with minimal active career growth opportunities. Working on this product would focus on compliance, manufacturing, and regulatory maintenance rather than commercial expansion or innovation.
Worked on SELENOMETHIONINE SE 75 at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.